Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001019687-16-006040
Filing Date
2016-04-29
Accepted
2016-04-29 17:24:42
Documents
4
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 XENETIC BIOSCIENCES, INC. ANNUAL REPORT xenetic_10ka1-123115.htm 10-K/A 201098
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_10k-ex3101.htm EX-31.1 11517
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_10k-ex3102.htm EX-31.2 11225
4 CERTIFICATION xenetic_10k-ex3201.htm EX-32.1 4914
  Complete submission text file 0001019687-16-006040.txt   229956
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-178082 | Film No.: 161608510
SIC: 2834 Pharmaceutical Preparations